The most significant economic "spinoff" from the space program was not trivial consumer products. Instead, the Apollo program's immense demand for early semiconductors—at one point 75% of global demand—scaled the industry far faster than the consumer market would have alone.

Scientists constrained by limited grant funding often avoid risky but groundbreaking hypotheses. AI can change this by computationally generating and testing high-risk ideas, de-risking them enough for scientists to confidently pursue ambitious "home runs" that could transform their fields.

Building the first large-scale biological datasets, like the Human Cell Atlas, is a decade-long, expensive slog. However, this foundational work creates tools and knowledge that enable subsequent, larger-scale projects to be completed exponentially faster and cheaper, proving a non-linear path to discovery.

Pure, curiosity-driven research into quantum physics over a century ago, with no immediate application in sight, became the foundation for today's multi-billion dollar industries like lasers, computer chips, and medical imaging. This shows the immense, unpredictable ROI of basic science.

Describing space exploration as a 'cash grab' isn't cynical; it's a recognition of fundamental human motivation. Money acts as 'proof of work,' incentivizing people to dedicate time and resources to difficult, long-term goals. Without a profit motive, ambitious endeavors like becoming a multi-planetary species would never attract the necessary capital and talent.

Frame moonshot projects like Google's Waymo not as singular bets, but as platforms for innovation. Even if the primary goal fails, the project should be structured to spin off valuable 'side effects'—advances in component technologies like AI, mapping, or hardware that benefit the core business.

Companies pursuing revolutionary technologies like autonomous driving (Waymo) or VR (Reality Labs) must endure over a decade of massive capital burn before profitability. This affirms venture capital's core role in funding these long-term, high-risk, high-reward endeavors.

The economic value of extending healthy life is astronomical. One research team estimated a single year of added healthspan is worth $38 trillion to the US economy, a figure experts believe is still an underestimate. This reframes geroscience investment as a massive economic opportunity, not a cost.

Companies are spending unsustainable amounts on AI compute, not because the ROI is clear, but as a form of Pascal's Wager. The potential reward of leading in AGI is seen as infinite, while the cost of not participating is catastrophic, justifying massive, otherwise irrational expenditures.